Parkinson's disease Symptoms Before and After Levodopa-Carbidopa Intestinal Gel: a Subanalysis From the COSMOS Study

被引：0
|
作者：
Fasano, A. [1 ]
Toomsoo, T. [2 ]
Hassin-Baer, S.
Van Kesteren, M.
Parra, J. [3 ]
Femia, S.
Chico, S.
Alobaidi, A.
Szasz, J.
机构：
[1] Div Neurol, Toronto, ON, Canada
[2] Dept Neurol, Tallinn, Estonia
[3] AbbVie Inc, N Chicago, IL USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
OPR-150
引用
收藏
页码：164 / 164
页数：1
相关论文
共 50 条
  • [1] A urodynamic study on the effects of levodopa-carbidopa intestinal gel on urinary symptoms in Parkinson's disease
    Rinaldi, D.
    Voglino, O.
    Mattioli, M.
    Tubaro, A.
    Pontieri, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 454 - 454
  • [2] Levodopa-carbidopa intestinal gel for advanced Parkinson's disease
    Bohlega S
    Abou Al-Shaar H
    Alkhairallah T
    中华物理医学与康复杂志, 2016, (03) : 179 - 179
  • [3] Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: long-term results from COSMOS
    Fasano, Alfonso
    Garcia-Ramos, Rocio
    Gurevich, Tanya
    Jech, Robert
    Bergmann, Lars
    Sanchez-Solino, Olga
    Parra, Juan Carlos
    Simu, Mihaela
    JOURNAL OF NEUROLOGY, 2023, 270 (05) : 2765 - 2775
  • [4] Non-motor Symptoms after Treatment with Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson's Disease: Analysis of the COSMOS Observational Study
    Johansson, A.
    Tomantschger, V.
    Kovacs, N.
    Dulamea, A.
    Sanchez-Solino, O.
    Bergmann, L.
    Parra, J. Carlos
    Fasano, A.
    MOVEMENT DISORDERS, 2020, 35 : S322 - S323
  • [5] Continuous infusion of levodopa-carbidopa intestinal gel in Parkinson's disease
    Guthikonda, Lalitha N.
    Lyons, Kelly E.
    Pahwa, Rajesh
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2014, 3 (04) : 331 - 333
  • [6] Effect of levodopa-carbidopa intestinal gel on lower urinary tract symptoms in Parkinson's disease: an Urodynamic study
    Rinaldi, D.
    Voglino, O.
    Tubaro, A.
    Pontieri, F. E.
    MOVEMENT DISORDERS, 2022, 37 : S464 - S464
  • [7] Efficacy and safety of Levodopa-Carbidopa Intestinal Gel in the treatment of Parkinson's Disease
    Londero, E.
    dos Santos, A. P.
    Braga, R.
    de Barros, R.
    dos Reis, L.
    Freire, G.
    MOVEMENT DISORDERS, 2021, 36 : S220 - S220
  • [8] Suicide in Parkinson's Disease Patients Treated With Levodopa-Carbidopa Intestinal Gel
    Zorko, Nika
    Kojovic, Maja
    Flisar, Dusan
    Pirtosek, Zvezdan
    Kramberger, Milica Gregoric
    MOVEMENT DISORDERS, 2015, 30 (10) : 1434 - 1435
  • [9] Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review
    Wirdefeldt, Karin
    Odin, Per
    Nyholm, Dag
    CNS DRUGS, 2016, 30 (05) : 381 - 404
  • [10] Effect of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients
    Takei, T.
    Uozumi, T.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 742 - 742
12345